Lu 177 Dotate Reduce the Risk of Cancer Spreading Growing, or Getting worse by 79% for patients with metastatic Net, as campared to a large dese of long acting octreetide. pin.it
Peptide receptor radionuclide therapy (PRRT) is fast proving to be a paradigm-shifting approach to the treatment of neuroendocrine tumors.
For more information on PRRT, do call us at +91 98111 27080,
or write to us at info@nuclearmedicinetherapy.in or visit https://nuclearmedicinetherapy.in/treatments/prrt